-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
CTO, BuddyTV
-
Partner, Advanced Technology Ventures
-
Founder and Managing Partner, IA Ventures
-
Senior Partner, Bessemer Venture Partners
-
Meet All the Xconomists ›
-
Co-Founder and former CEO, Intellikine
-
Partner, Kleiner Perkins Caufield & Byers
-
Dean, College of Engineering, University of Washington
-
Co-Founder, VP of Technology, Entropic Communications
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up
|
Luke Timmerman |
03/04/11 |
Seattle
|
|
Marina Biotech Nabs $5.1M
|
Luke Timmerman |
02/10/11 |
Seattle
|
|
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars
|
Luke Timmerman |
01/28/11 |
National
|
|
EyeGate Adds $6M to Series D
|
Erin Kutz |
01/06/11 |
Boston
|
|
Alnylam Lays Out 2015 Goals
|
Luke Timmerman |
01/06/11 |
Boston
|
|
AVI Partners With Karolinska
|
Luke Timmerman |
01/05/11 |
Seattle
|
|
Santaris Gets $14M From Pfizer
|
Luke Timmerman |
01/04/11 |
San Diego
|
|
How Michael French, a Military Brat Turned Dealmaker, Kept Marina Biotech Alive
|
Luke Timmerman |
12/20/10 |
Seattle
|
|
AVI Names New CEO
|
Luke Timmerman |
12/13/10 |
Seattle
|
|
Alnylam CEO Looks to the Future, Dicerna Plumps Up Kyowa Hakko Pact, Momenta Sells $57.4M Stock Offering, & More Boston-Area Life Sciences News
|
Erin Kutz |
12/10/10 |
Boston
|
|
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi
|
Luke Timmerman |
12/06/10 |
Boston
|
|
NanoBio Nabs $6M from Gates Foundation for Nasal Spray Vaccine
|
Luke Timmerman |
11/30/10 |
Detroit
|
|
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News
|
Erin Kutz |
11/19/10 |
Boston
|
|
Roche Cuts to Hit Hundreds of Genentech Workers; Scientific Staff is Spared
|
Luke Timmerman |
11/17/10 |
San Francisco
|
|
Roche Dumps RNAi, Sends Shock Waves Through Alnylam, Tekmira
|
Luke Timmerman |
11/17/10 |
National
|
|
Marina Biotech Adds $3.3M
|
Luke Timmerman |
11/08/10 |
Seattle
|
|
Alkermes Drops on FDA Rejection, Glaxo’s SR One Backs Dicerna, Biogen Reworks Genentech Alliance, & More Boston-Are Life Sciences News
|
Erin Kutz |
10/22/10 |
Boston
|
|
Sangamo, With a Lock on Genetic Switch Technology, Seeks to Morph Into Drugmaker
|
Luke Timmerman |
10/18/10 |
San Francisco
|
|
Mike Huckman, Former CNBC Reporting Ace, Joins Stellar Lineup at Boston’s War on Cancer
|
Luke Timmerman |
10/14/10 |
Boston
|
|
La Jolla Institute Nabs $12.6M RNAi Grant
|
Luke Timmerman |
10/08/10 |
San Diego
|
|
Where Will the Next Gleevec Come From? Xconomy Forum Looks At the Edge of Cancer R&D
|
Luke Timmerman |
10/05/10 |
Boston
|
|
Alnylam Cuts 25-30% of Workforce, As Novartis Alliance Ends
|
Luke Timmerman |
09/23/10 |
Boston
|
|
Tekmira Gets $5.8M from Hana
|
Luke Timmerman |
09/22/10 |
Seattle
|
|
RXi, EyeGate Team Up
|
Gregory T. Huang |
09/22/10 |
Boston
|
|
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond
|
Luke Timmerman |
09/15/10 |
National
|
|
Lee Hood & Team Moving to South Lake Union, Mirina Vs. Marina, Trubion Gets Acquired, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/19/10 |
Seattle
|
|
Quark Nabs Novartis Option Deal
|
Luke Timmerman |
08/18/10 |
San Francisco
|
|
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names
|
Luke Timmerman |
08/16/10 |
Seattle
|
|
Marina Gets RNAi Delivery Tools for $5M
|
Luke Timmerman |
07/28/10 |
Seattle
|
|
MDRNA Does Reverse Stock Split
|
Luke Timmerman |
07/21/10 |
Seattle
|
|
Page 2 of
6 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.